IN2014DN09789A - - Google Patents

Info

Publication number
IN2014DN09789A
IN2014DN09789A IN9789DEN2014A IN2014DN09789A IN 2014DN09789 A IN2014DN09789 A IN 2014DN09789A IN 9789DEN2014 A IN9789DEN2014 A IN 9789DEN2014A IN 2014DN09789 A IN2014DN09789 A IN 2014DN09789A
Authority
IN
India
Prior art keywords
lactic acid
oligomeric lactic
trimer
integer
composition
Prior art date
Application number
Inventor
Olov Sterner
Sören Kulstad
Jeanette Robertsson
Malgorzata Sznitowska
Werner Schubert
Original Assignee
Laccure Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laccure Ab filed Critical Laccure Ab
Publication of IN2014DN09789A publication Critical patent/IN2014DN09789A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C07C69/675—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids of saturated hydroxy-carboxylic acids
    • C07C69/68—Lactic acid esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polyesters Or Polycarbonates (AREA)

Abstract

A composition comprising i) oligomeric lactic acid with the following formula (I) wherein n is an integer from 2 to 20 , from 2 to 19 , or from 2 to 18 , and wherein from about 10 to about 20% w/w of the total weight of the oligomeric lactic acid is a trimer HL3, having n equal to 2, wherein the number average molecular weight M,, of the oligomeric lactic acid is from about 200 to about 500 , and ii) a mucoadhesive agent.
IN9789DEN2014 2012-07-16 2014-11-19 IN2014DN09789A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA201270431 2012-07-16
PCT/EP2013/064265 WO2014012805A1 (en) 2012-07-16 2013-07-05 Pharmaceutical compositions containing oligomeric lactic acid

Publications (1)

Publication Number Publication Date
IN2014DN09789A true IN2014DN09789A (en) 2015-07-31

Family

ID=48793207

Family Applications (1)

Application Number Title Priority Date Filing Date
IN9789DEN2014 IN2014DN09789A (en) 2012-07-16 2014-11-19

Country Status (17)

Country Link
US (1) US9370502B2 (en)
EP (1) EP2872117B1 (en)
JP (1) JP6149109B2 (en)
KR (1) KR102089117B1 (en)
CN (1) CN104470498B (en)
AU (1) AU2013292179B2 (en)
BR (1) BR112015001006B1 (en)
CA (1) CA2875784C (en)
DK (1) DK2872117T3 (en)
ES (1) ES2652251T3 (en)
IN (1) IN2014DN09789A (en)
MX (1) MX356750B (en)
NO (1) NO2872117T3 (en)
PL (1) PL2872117T3 (en)
RU (1) RU2627470C2 (en)
WO (1) WO2014012805A1 (en)
ZA (1) ZA201409039B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX387286B (en) 2015-09-29 2025-03-18 Kimberly Clark Co SYNERGISTIC COMPOSITION FOR MAINTAINING A HEALTHY MICROFLORA BALANCE.
CN105327405B (en) * 2015-10-23 2019-01-29 华南理工大学 Drug-loaded stent for treating cervicitis and preparation method thereof
BR112019015239A2 (en) 2017-02-28 2020-04-14 Kimberly Clark Co composition, and, method to maintain a healthy microflora balance in the urogenital area of a patient in need of it.
CN109288793B (en) * 2018-07-27 2021-07-16 江苏中天药业有限公司 Spray for adjusting pH environment of vagina and preparation method thereof
US20250161348A1 (en) 2022-03-01 2025-05-22 Combe Incorporated Process for preparation of compositions of oligomers of lactic acid

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6552024B1 (en) * 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
AU2002325614A1 (en) * 2001-08-16 2003-03-03 Pharmacon-Forschung Und Beratung Gmbh Compounds containing lactic acid elements, method for the production and use thereof as pharmaceutically active substances
SE528337C2 (en) * 2004-06-23 2006-10-24 Nestor Medical Ab Composition comprising lactic acid and lactoferrin, or a peptide fragment thereof, and use of this composition for treating conditions in the urogenital system
RU2308951C2 (en) * 2005-08-18 2007-10-27 Виктор Игоревич Высоков Complex method for preventing vaginal dysbacteriosis (variants)
WO2008062446A2 (en) * 2006-09-14 2008-05-29 Alembic Limited An extended release composition of levetiracetam, which exhibits no adverse food effect
DK2142186T3 (en) * 2007-03-30 2014-08-04 Laccure Ab Use of oligomers of lactic acid in the treatment of gynecological infections

Also Published As

Publication number Publication date
EP2872117B1 (en) 2017-09-27
CA2875784C (en) 2020-03-10
MX2015000564A (en) 2015-04-10
KR102089117B1 (en) 2020-04-16
ZA201409039B (en) 2020-01-29
ES2652251T3 (en) 2018-02-01
PL2872117T3 (en) 2018-02-28
RU2015104974A (en) 2016-09-10
WO2014012805A1 (en) 2014-01-23
AU2013292179A1 (en) 2015-01-15
BR112015001006A2 (en) 2017-06-27
AU2013292179B2 (en) 2017-03-30
NO2872117T3 (en) 2018-02-24
WO2014012805A9 (en) 2014-12-31
US20150164848A1 (en) 2015-06-18
KR20150036091A (en) 2015-04-07
MX356750B (en) 2018-06-12
BR112015001006B1 (en) 2022-05-17
JP2015526413A (en) 2015-09-10
DK2872117T3 (en) 2018-01-08
CA2875784A1 (en) 2014-01-23
JP6149109B2 (en) 2017-06-14
CN104470498A (en) 2015-03-25
CN104470498B (en) 2017-08-08
EP2872117A1 (en) 2015-05-20
RU2627470C2 (en) 2017-08-08
US9370502B2 (en) 2016-06-21

Similar Documents

Publication Publication Date Title
MX2015008100A (en) Compositions comprising a triazole compound.
MY188960A (en) Cyclic boronic acid ester derivatives and therapeutic uses thereof
MX349827B (en) Nitrogen containing compounds and their use.
MX346602B (en) Amidine substituted beta - lactam compounds, their preparation and use as antibacterial agents.
WO2011153157A3 (en) Benzoquinolone inhibitors of vmat2
IN2014DN09346A (en)
IN2015DN00960A (en)
PH12014500137A1 (en) Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions
MX2015013806A (en) Polyetheramines based on 1,3-dialcohols.
MX2013004759A (en) Oxime compounds as hdl-cholesterol raising agents.
NZ705313A (en) Novel 4,6-disubstituted aminopyrimidine derivatives
MX2014015197A (en) Treatment and prevention of cardiovascular disease and thrombosis.
WO2013072528A3 (en) Substituted n-(tetrazol-5-yl)- and n-(triazol-5-yl)pyridin-3-yl-carboxamide compounds and their use as herbicides
IN2014DN09789A (en)
MX2015009852A (en) 2-oxo-1,3-dioxolane-4-carboxamide building blocks, their preparation and use.
MX2012012993A (en) Tetracycline compositions.
SG10201900541QA (en) Derivatives of xanthone compounds
MX349373B (en) Novel pyrazine derivatives.
MX342947B (en) Treatment of type 2 diabetes.
PH12014500321A1 (en) Novel substituted cyclohexane compounds
MX354280B (en) Dibenzylamine hydrophobe.
IN2015DN02358A (en)
UA104102C2 (en) α-CRYSTALLINE FORM OF CARBABENZPYRIDE
WO2014052081A3 (en) Functionalized oligomers
UA56041U (en) 1,3-dimethyl-7-n-methylbenzene-8-n-hydrazinoxanthine exhibiting diuretic action